Published in Genet Test on December 01, 2008
Public opinion about the importance of privacy in biobank research. Am J Hum Genet (2009) 3.85
The role of distress in uptake and response to predisposition genetic testing: the BMPR2 experience. Genet Test Mol Biomarkers (2011) 0.84
Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med (2006) 9.17
Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med (2011) 6.74
A randomized study of endobronchial valves for advanced emphysema. N Engl J Med (2010) 6.23
An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med (2012) 5.37
Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst (2004) 3.86
Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res (2006) 3.06
Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med (2003) 2.94
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med (2007) 2.86
Cigarette warning label policy alternatives and smoking-related health disparities. Am J Prev Med (2012) 2.72
The feasibility of smoking reduction: an update. Addiction (2005) 2.44
Improving colorectal cancer screening in primary care practice: innovative strategies and future directions. J Gen Intern Med (2007) 2.26
Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med (2006) 2.22
A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry (2012) 2.03
Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results. Am J Respir Crit Care Med (2009) 1.78
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol (2009) 1.78
Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial. Lancet Respir Med (2013) 1.69
Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use? Am J Addict (2008) 1.68
alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note. Chest (2008) 1.60
Treatment of pulmonary arterial hypertension: a preliminary decision analysis. Chest (2003) 1.54
Neurocognitive impairment in obstructive sleep apnea. Chest (2012) 1.50
Evaluation of current tobacco curriculum at 12 US medical schools. J Cancer Educ (2004) 1.47
COPD and lung cancer: are they both airways diseases? Chest (2010) 1.41
Obese man treated with drotrecogin alfa (activated). Ann Pharmacother (2003) 1.38
Internet-based intervention for mental health and substance use problems in disaster-affected populations: a pilot feasibility study. Behav Ther (2006) 1.36
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum (2007) 1.35
Tobacco control efforts in managed care: what do the doctors think? Am J Manag Care (2004) 1.33
Do point prevalence and prolonged abstinence measures produce similar results in smoking cessation studies? A systematic review. Nicotine Tob Res (2010) 1.32
Health behavior change among women with recent familial diagnosis of breast cancer. Prev Med (2004) 1.31
Reactivity to nicotine cues over repeated cue reactivity sessions. Addict Behav (2007) 1.31
Patient and caregiver interest in internet-based cancer services. Cancer Pract (2002) 1.31
Defining quit attempts: what difference does a day make? Addiction (2005) 1.29
Trends in the use of premium and discount cigarette brands: findings from the ITC US Surveys (2002-2011). Tob Control (2013) 1.27
Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. Ann Behav Med (2007) 1.27
Gender differences in craving and cue reactivity to smoking and negative affect/stress cues. Am J Addict (2012) 1.25
Pneumothorax in cystic fibrosis. Chest (2005) 1.25
Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem. Chest (2005) 1.22
Bupropion SR and contingency management for adolescent smoking cessation. J Subst Abuse Treat (2010) 1.22
Relationship between tobacco control policies and the delivery of smoking cessation services in nonprofit HMOs. J Natl Cancer Inst Monogr (2005) 1.22
Physician assistants as providers of surgically induced abortion services. Am J Public Health (2004) 1.19
Tobacco-control policies in 11 leading managed care organizations: progress and challenges. Eff Clin Pract (2002) 1.16
Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Thorax (2007) 1.12
A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend (2009) 1.10
Predictors of cessation pharmacotherapy use among black and non-Hispanic white smokers. Nicotine Tob Res (2011) 1.10
Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med (2010) 1.09
IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency. Am J Respir Cell Mol Biol (2007) 1.08
N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict (2010) 1.07
Secondhand smoke exposure in young people and parental rules against smoking at home and in the car. Public Health Rep (2011) 1.05
Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency. Clin Gastroenterol Hepatol (2005) 1.04
Evidence for greater cue reactivity among low-dependent vs. high-dependent smokers. Addict Behav (2010) 1.02
Predictors of quit attempts and abstinence among smokers not currently interested in quitting. Nicotine Tob Res (2012) 1.01
Association between ovarian hormones and smoking behavior in women. Exp Clin Psychopharmacol (2012) 1.01
Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. J Natl Cancer Inst Monogr (2005) 0.99
Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism. J Clin Invest (2003) 0.99
Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report. Eval Health Prof (2005) 0.98
Lung and bronchus cancer disparities in South Carolina: epidemiology and strategies for prevention. J S C Med Assoc (2006) 0.96
A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict (2010) 0.95
Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobes. Eur Radiol (2012) 0.94
Occasional smoking in college: who, what, when and why? Addict Behav (2011) 0.94
End-of-life care and African Americans: voices from the community. J Palliat Med (2005) 0.93
Screening for colorectal cancer on the front line. Am J Gastroenterol (2003) 0.92
A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav (2013) 0.91
Level of cigarette consumption and quit behavior in a population of low-intensity smokers--longitudinal results from the International Tobacco Control (ITC) survey in Mexico. Addict Behav (2012) 0.91
Mortality in individuals with severe deficiency of alpha1-antitrypsin: findings from the National Heart, Lung, and Blood Institute Registry. Chest (2005) 0.91
Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. Chest (2013) 0.90
Attention-deficit/hyperactivity disorder confounds nicotine withdrawal self-report in adolescent smokers. Am J Addict (2010) 0.90
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival. Chest (2008) 0.90
The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. Ann Epidemiol (2009) 0.89
Menstrual cycle and cue reactivity in women smokers. Nicotine Tob Res (2009) 0.89
Detection of alpha-1 antitrypsin deficiency by respiratory therapists: experience with an educational program. Respir Care (2013) 0.88
Implementation of systems strategies for breast and cervical cancer screening services in health maintenance organizations. Am J Manag Care (2003) 0.88
Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency. Respir Res (2012) 0.88
A 56-year-old woman with arm pain, dyspnea, and an elevated diaphragm. Chest (2008) 0.87
The relationship between impulsivity, risk-taking propensity and nicotine dependence among older adolescent smokers. Addict Behav (2012) 0.87
Quality of life pilot intervention for breast cancer patients: use of social cognitive theory. Palliat Support Care (2003) 0.87
Treating nicotine dependence during pregnancy and postpartum: understanding clinician knowledge and performance. Patient Educ Couns (2002) 0.87
Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial. Nicotine Tob Res (2013) 0.87
Challenges to research in urban community health centers. Am J Public Health (2006) 0.87
Impact of self-initiated pre-quit smoking reduction on cessation rates: results of a clinical trial of smoking cessation among female prisoners. Addict Behav (2010) 0.86
Chest ultrasound for "Dummies". Chest (2003) 0.86
Circulating polymers in α1-antitrypsin deficiency. Eur Respir J (2014) 0.85
Empiric auto-titrating CPAP in people with suspected obstructive sleep apnea. J Clin Sleep Med (2010) 0.85
Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunities. Cleve Clin J Med (2007) 0.85
Genetic testing for alpha1-antitrypsin deficiency. Genet Med (2004) 0.85
Stopping smoking: carpe diem? Tob Control (2006) 0.84
Scleroderma lung disease: "if you don't know where you are going, any road will take you there". Am J Respir Crit Care Med (2008) 0.84
Reactivity to in vivo marijuana cues among cannabis-dependent adolescents. Addict Behav (2010) 0.83
Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial. Nicotine Tob Res (2011) 0.83
Expanded carrier screening panels-does bigger mean better? J Community Genet (2013) 0.83
Family-focused smoking cessation:enhanced efficacy by the addition of partner support and group therapy. Subst Abus (2004) 0.83
Weight gain as an impediment to cigarette smoking cessation: a lingering problem in need of solutions. Prev Med (2007) 0.83
The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction. COPD (2012) 0.82
Asthma and allergy in alpha-1 antitrypsin deficiency. Respir Med (2006) 0.82
The effect of a cryotherapy gel wrap on the microcirculation of skin affected by chronic venous disorders. J Adv Nurs (2011) 0.82
Use of stop-smoking medications in the United States before and after the introduction of varenicline. Addiction (2014) 0.82
The impact of age on outcomes in chronic obstructive pulmonary disease differs by relationship status. J Behav Med (2013) 0.81
Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency. Epigenetics (2012) 0.81
Physician perspectives on end-of-life care: factors of race, specialty, and geography. Palliat Support Care (2006) 0.81